Cited by 3Cancer-related Molecular PathwaysCell death mechanisms and regulationPI3K/AKT/mTOR signaling in cancer

The DOI matches its Crossref record; the references it cites are not checked yet.

Simplify p53: just an activator

Open access
Engeland, Kurt·2015·Oncotarget

Abstract

‘Simplify your life. ’ In research- contrasting such a popular concept- we are challenged by an ever-expanding plethora of observations and accumulation of knowledge. This leads to the development of increasingly complex models trying to explain all aspects of our world that are subject to scientific endeavor. Recently, a well-known object of study from the life sciences, the tumor suppressor p53, has emerged as an example for which diversity of its apparent functions has actually decreased. p53 has long been described to function as a transcription factor. Initially, the cyclin-dependent kinase inhibitor gene CDKN1A (p21WAF1/CIP1) had been discovered as transcriptionally activated by p53 [1]. Similar to this early observation, many genes were detected to be activated by the tumor suppressor. Often the genes

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.3032

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The transcription factor p53 itself is solely an activator of transcription.

    “The transcription factor p53 itself is solely an activator of transcription. 53, 232”

    From Census and evaluation of p53 target genes (2017) · cites this paper as [232]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

References 7 · Cited by 3

Research works printed but not linked: 2

  1. Menendez, et al. Nat. Rev. Cancer. 2009; 9:724–737.
  2. Böhlig, et al. J. Biomed. Biotechnol. 2011; 2011:464916.

Metadata

Authors
Engeland, K.
Affiliations
Leipzig University (DE)
Corresponding author
Engeland, Kurt
Venue
Oncotarget
Published
2014-12-16
Volume
6
Issue
1
Pages
3-4
ISSN
1949-2553 (ISSN-L)
OpenAlex
W1853981280
Cited by
3
References
7
Citations by year
2018: 1 · 2017: 1 · 2016: 1
Type
journal article
Language
en
Open access
Locations
  • Oncotarget (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
p53, transcriptional activation, tumor suppressor, p21, cyclin-dependent kinase inhibitors, gene expression regulation
MeSH terms
Humans, Neoplasms, Gene Expression Regulation, Neoplastic, Genes, p53, Tumor Suppressor Protein p53, Computational Biology, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review